These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9236918)
21. Preparation of F(ab')2 mu fragments from rat IgM monoclonal antibodies and their application to the enzyme immunoassay of mouse interleukin-6. Inouye K; Morimoto K J Immunol Methods; 1994 May; 171(2):239-44. PubMed ID: 8195591 [TBL] [Abstract][Full Text] [Related]
22. Cross-reactivity of human IgG anti-F(ab')2 antibody with DNA and other nuclear antigens. Williams RC; Malone CC; Cimbalnik K; Presley MA; Roux KH; Strelets L; Silvestris F Arthritis Rheum; 1997 Jan; 40(1):109-23. PubMed ID: 9008607 [TBL] [Abstract][Full Text] [Related]
23. Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. Hirsch R; Bluestone JA; DeNenno L; Gress RE Transplantation; 1990 Jun; 49(6):1117-23. PubMed ID: 2141740 [TBL] [Abstract][Full Text] [Related]
24. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451 [TBL] [Abstract][Full Text] [Related]
25. Preparation of F(ab')2 fragments from monoclonal mouse IgG1 suitable for use in radioimaging. Kurkela R; Vuolas L; Vihko P J Immunol Methods; 1988 Jun; 110(2):229-36. PubMed ID: 3132507 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of bifunctional antibodies for immunoassays. DeSilva BS; Wilson GS Methods; 2000 Sep; 22(1):33-43. PubMed ID: 11020315 [TBL] [Abstract][Full Text] [Related]
29. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments. Narula J; Petrov A; Bianchi C; Ditlow CC; Lister BC; Dilley J; Pieslak I; Chen FW; Torchilin VP; Khaw BA Circulation; 1995 Aug; 92(3):474-84. PubMed ID: 7634463 [TBL] [Abstract][Full Text] [Related]
30. Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes. Chapoval AI; Nelson H; Thibault C J Immunol; 1995 Aug; 155(3):1296-303. PubMed ID: 7636196 [TBL] [Abstract][Full Text] [Related]
31. [Anti-tumor effects of bispecific monoclonal antibody targeted human monocytes-macrophages on hepatoma cells]. Wang Q; Chen Z; Wang W Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):96-9. PubMed ID: 8758438 [TBL] [Abstract][Full Text] [Related]
32. The specificity of antibodies to the F(ab')2 fragment of human IgG. Heimer R; Wolfe LD; Abruzzo JL Arthritis Rheum; 1985 May; 28(5):562-8. PubMed ID: 3873943 [TBL] [Abstract][Full Text] [Related]
33. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen. Temponi M; Gold AM; Ferrone S Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670 [TBL] [Abstract][Full Text] [Related]
34. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor. Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575 [TBL] [Abstract][Full Text] [Related]
35. The mechanism involved in the conversion of thyrotropin receptor-bound blocking-type immunoglobulin G (IgG) to the stimulating-type by anti-human IgG antibodies. Taniguchi S; Yoshida A; Shigemasa C; Mitani Y; Ueta Y; Urabe K; Mashiba H Endocrinology; 1990 Feb; 126(2):796-803. PubMed ID: 2153526 [TBL] [Abstract][Full Text] [Related]
36. Nanogold-polyaniline-nanogold microspheres-functionalized molecular tags for sensitive electrochemical immunoassay of thyroid-stimulating hormone. Cui Y; Chen H; Hou L; Zhang B; Liu B; Chen G; Tang D Anal Chim Acta; 2012 Aug; 738():76-84. PubMed ID: 22790703 [TBL] [Abstract][Full Text] [Related]
37. Family distribution of anti-F(ab')2 antibodies in relatives of patients with systemic lupus erythematosus. Silvestris F; Searles RP; Bankhurst AD; Williams RC Clin Exp Immunol; 1985 May; 60(2):329-38. PubMed ID: 3874025 [TBL] [Abstract][Full Text] [Related]
38. Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms. Link BK; Kostelny SA; Cole MS; Fusselman WP; Tso JY; Weiner GJ Int J Cancer; 1998 Jul; 77(2):251-6. PubMed ID: 9650561 [TBL] [Abstract][Full Text] [Related]
39. Spectrophotometric enzyme-amplified immunoassay for thyroid stimulating hormone. Wilson R Analyst; 1992 Oct; 117(10):1547-51. PubMed ID: 1443631 [TBL] [Abstract][Full Text] [Related]
40. A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb. Ochi Y; Kajita Y; Hachiya T; Hamaoki M Med Hypotheses; 2012 Jun; 78(6):781-6. PubMed ID: 22472575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]